SMND-309 promotes neuron survival through the activation of the PI3K/Akt/CREB-signalling pathway

Abstract

Context In clinical practice, the promotion of neuron survival is necessary to recover neurological functions after the onset of stroke. Objective This study aimed to investigate the post-ischaemic neuroprotective effect of SMND-309, a novel metabolite of salvianolic acid, on differentiated SH-SY5Y cells. Materials and methods SH-SY5Y cells were differentiated by pre-treating with 5 mM all-transretinoic acid for 6 d. The differentiated SH-SY5Y cells were exposed to oxygen-glucose deprivation (OGD) for 2 h and reperfusion (R) for 24 h to induce OGD/R injury. After OGD injury, differentiated SH-SY5Y cells were treated with or without SMND-309 (5, 10, 20 mM) for another 24 h. Cell viability was detected through Cell counting kit-8 assay and lactate dehydrogenase leakage assay. Apoptosis was evaluated through flow cytometry, caspase-3 activity assay. Changes in protein levels were assessed through Western blot. Results SMND-309 ameliorated the degree of injury in the differentiated SH-SY5Y cells by increasing cell viabilities (5 mM, 65.4% ± 4.1%; 10 mM, 69.8% ± 3.7%; 20 mM, 75.3% ± 5.1%) and by reducing LDH activity (20 mM, 2.5 fold) upon OGD/R stimulation. Annexin V-fluorescein isothiocyanate/propidium iodide staining results suggested that apoptotic rate of differentiated SH-SY5Y cells decreased from 43.8% induced by OGD/R injury to 19.2% when the cells were treated with 20 mM SMND-309. SMND-309 significantly increased the Bcl-2 level of the injured differentiated SH-SY5Y cells but decreased the caspase-3 activity of these cells by 1.6-fold. In contrast, SMND-309 did not affect the Bax level of these cells. SMND-309 evidently increased the protein expression of BDNF when Akt and CREB were activated. This function was antagonized by the addition of LY294002. Conclusion SMND-309 can prevent neuronal cell death in vitro. This process may be related to the activation of the PI3K/Akt/CREB-signalling pathway.ARTICLE HISTORY

CREB-TFDP3 Promotes Prostate Carcinoma Cell Growth by Inhibiting E2F1-Dependent Apoptosis

“…CREB speci c shRNA and CREB inhibitors, such as lapatinib and KG501, has been shown to reverse the transformed phenotype and growth characteristics of breast cancer cells (26). Our results support the rationale of targeting CREB or CREB related pathways for the treatment of cancer (27,28).…”

Botanicals as Modulators of Neuroplasticity: Focus on BDNF

“…Furthermore, SMND-309 (5, 10, and 20 μ M for 24 h), the metabolite produced in the brain and heart of rats after SalB oral administration, restored the mBDNF protein expression in the human neuroblastoma cell line SH-SY5Y subjected for 2 h to OGD/R [ 133 ].…”

Protective effects of macamides fromLepidium meyeniiWalp. against corticosterone-induced neurotoxicity in PC12 cells

“…CREB is phosphorylated at Ser133, and p-CREB is its active form. Activated CREB can improve cell survival by regulating BDNF expression, 65,66 which is considered an important factor for neuronal survival. 35 In this study, M 18:3 increased the expression levels of p-CREB and BDNF.…”